121 related articles for article (PubMed ID: 30714447)
1. Wilms tumor 1 expression: addressing the 'elephant' in MDS.
Madanat YF; Sekeres MA
Leuk Lymphoma; 2019 Mar; 60(3):566-567. PubMed ID: 30714447
[No Abstract] [Full Text] [Related]
2. Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS.
Pan D; Zhao W; Jiang Q; Yin C; He H; Liao L; Ye J; Dai M
Leuk Lymphoma; 2023 Apr; 64(4):856-864. PubMed ID: 36905177
[TBL] [Abstract][Full Text] [Related]
3. Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome.
Mashima K; Ikeda T; Toda Y; Ito S; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Fujiwara S; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Leuk Lymphoma; 2019 Mar; 60(3):703-710. PubMed ID: 30188227
[TBL] [Abstract][Full Text] [Related]
4. Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome.
Nagasaki J; Aoyama Y; Hino M; Ido K; Ichihara H; Manabe M; Ohta T; Mugitani A
Acta Haematol; 2017; 137(1):32-39. PubMed ID: 27866185
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Kobayashi S; Ueda Y; Nannya Y; Shibayama H; Tamura H; Ogata K; Akatsuka Y; Usuki K; Ito Y; Okada M; Suzuki T; Hata T; Matsuda A; Tohyama K; Kakumoto K; Koga D; Mitani K; Naoe T; Sugiyama H; Takaku F
Cancer Biomark; 2016 Mar; 17(1):21-32. PubMed ID: 27062571
[TBL] [Abstract][Full Text] [Related]
6. Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis.
Sugiyama H
Methods Mol Med; 2002; 68():223-37. PubMed ID: 11901505
[No Abstract] [Full Text] [Related]
7. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
8. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
Yang JK; Li JL; Li ZG; Li ZG; Liu PJ; Li JY; Lü HR; Deng Q; Lin XM; Cao JN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of the Wilms' tumor 1 mRNA expression in childhood myelodysplastic syndrome].
Cheng YF; Zhang LP; Liu YR; Qin YZ; Wu J; Liu GL
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):536-40. PubMed ID: 22967413
[TBL] [Abstract][Full Text] [Related]
10. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes.
Li X; Wu L; Ying S; Chang C; Pu Q
Leuk Lymphoma; 2007 Mar; 48(3):601-4. PubMed ID: 17454605
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Wilms' Tumor 1 Gene in Bone Marrow of Patients with Myelodysplastic Syndrome and Its Clinical Significance].
Pan DQ; Zhao WS; Yin CX; He H; Lin R; Zhao K; Ye JY; Liu QF; Dai M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1501-1507. PubMed ID: 36208256
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
Tamura H; Dan K; Yokose N; Iwakiri R; Ohta M; Sakamaki H; Tohyama K; Kondo A; Hyodo H; Nakamura K; Yamashita T; Elisseeva OA; Oka Y; Oji Y; Sugiyama H; Ogata K
Leuk Res; 2010 Aug; 34(8):986-90. PubMed ID: 20031209
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the WT1 gene in myelodysplastic syndromes.
Hosoya N; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1998 Aug; 89(8):821-4. PubMed ID: 9765617
[TBL] [Abstract][Full Text] [Related]
15. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Ueda Y; Mizutani C; Nannya Y; Kurokawa M; Kobayashi S; Takeuchi J; Tamura H; Ogata K; Dan K; Shibayama H; Kanakura Y; Niimi K; Sasaki K; Watanabe M; Emi N; Teramura M; Motoji T; Kida M; Usuki K; Takada S; Sakura T; Ito Y; Ohyashiki K; Ogawa H; Suzuki T; Ozawa K; Imai K; Kasai M; Hata T; Miyazaki Y; Morita Y; Kanamaru A; Matsuda A; Tohyama K; Koga D; Tamaki H; Mitani K; Naoe T; Sugiyama H; Takaku F
Leuk Lymphoma; 2013 Jul; 54(7):1450-8. PubMed ID: 23110324
[TBL] [Abstract][Full Text] [Related]
17. [Wilms tumor gene (WT1) expression in blood cells from patients with myelodysplastic syndrome].
Abdulkadyrov KM; Gritsaev SV; Kapustin SI; Martynkevich IS; Blinov MN; Bessmel'tsev SS; Tiranova SA; Rugal' VI
Vopr Onkol; 2004; 50(6):668-71. PubMed ID: 15755060
[No Abstract] [Full Text] [Related]
18. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
19. [Changes of WT1 mRNA expression level in patients with myelodysplastic syndromes after hypomethylating agents and its prognostic significance].
Zhang HY; Geng SX; Li MM; Lai PL; Deng CX; Lu ZS; Huang X; Wang YL; Weng JY; Du X
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):417-421. PubMed ID: 31207708
[No Abstract] [Full Text] [Related]
20. Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.
Wu F; Oka Y; Tsuboi A; Elisseeva OA; Ogata K; Nakajima H; Fujiki F; Masuda T; Murakami M; Yoshihara S; Ikegame K; Hosen N; Kawakami M; Nakagawa M; Kubota T; Soma T; Yamagami T; Tsukaguchi M; Ogawa H; Oji Y; Hamaoka T; Kawase I; Sugiyama H
Leukemia; 2005 Feb; 19(2):268-74. PubMed ID: 15538407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
